Evidence map›Paper›PMID 39135092›Full record

ArticleActa neuropathologica communications2024

Macular structural integrity estimates are associated with Parkinson's disease genetic risk.

Santiago Diaz-Torres, Samantha Sze-Yee Lee, Natalia S Ogonowski, David A Mackey, Stuart MacGregor, Puya Gharahkhani, Miguel E Renteria

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Ocular manifestations in autism spectrum disorder.International journal of ophthalmology · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Santiago Diaz-TorresQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Samantha Sze-Yee LeeCentre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), The University of Western Australia, Perth, WA, Australia.
Natalia S OgonowskiQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
David A MackeyCentre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), The University of Western Australia, Perth, WA, Australia.
Stuart MacGregorQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Puya Gharahkhani *QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. puya.gharahkhani@qimrberghofer.edu.au.
Miguel E Renteria *QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. miguel.renteria@qimrberghofer.edu.au.ORCID 0000-0003-4626-7248

Funding

National Health and Medical Research Council Grants 1021105, 1126494, and 1121979Rebecca L. Cooper Medical Research Foundation F20231230
6 · The paper itself

Abstract

backgroundOptical coherence tomography (OCT) is a non-invasive technique to measure retinal layer thickness, providing insights into retinal ganglion cell integrity. Studies have shown reduced retinal nerve fibre layer (RNFL) and ganglion cell inner plexiform layer (GCIPL) thickness in Parkinson's disease (PD) patients. However, it is unclear if there is a common genetic overlap between the macula and peripapillary estimates with PD and if the genetic risk of PD is associated with changes in ganglion cell integrity estimates in young adults.

methodWestern Australian young adults underwent OCT imaging. Their pRNFL, GCIPL, and overall retinal thicknesses were recorded, as well as their longitudinal changes between ages 20 and 28. Polygenic risk scores (PRS) were estimated for each participant based on genome-wide summary data from the largest PD genome-wide association study conducted to date. We further evaluated whether PD PRS was associated with changes in thickness at a younger age. To evaluate the overlap between retinal integrity estimates and PD, we annotated and prioritised genes using mBAT-combo and performed colocalisation through the GWAS pairwise method and HyPrColoc. We used a multi-omic approach and single-cell expression data of the retina and brain through a Mendelian randomisation framework to evaluate the most likely causal genes. Genes prioritised were analysed for missense variants that could have a pathogenic effect using AlphaMissense.

resultsWe found a significant association between the Parkinson's disease polygenic risk score (PD PRS) and changes in retinal thickness in the macula of young adults assessed at 20 and 28 years of age. Gene-based analysis identified 27 genes common to PD and retinal integrity, with a notable region on chromosome 17. Expression analyses highlighted NSF, CRHR1, and KANSL1 as potential causal genes shared between PD and ganglion cell integrity measures. CRHR1 showed consistent results across multiple omics levels.

interpretationOur findings suggest that retinal measurements, particularly in young adults, could be a potential marker for PD risk, indicating a genetic overlap between retinal structural integrity and PD. The study highlights specific genes and loci, mainly on chromosome 17, as potential shared etiological factors for PD and retinal changes. Our results highlight the importance of further longitudinal studies to validate retinal structural metrics as early indicators of PD predisposition.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyParkinson DiseaseTomography, Optical CoherenceAdultFemaleHumansMacula LuteaMaleMultifactorial InheritanceRetinal Ganglion CellsYoung AdultCRHR1Ganglion cellGeneticsKANSL1NSFParkinson’s diseaseRetina

Identifiers

PMID39135092
PMCPMC11320880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.